Quality & Analytical Architecture
Metabolic Vitals treats evidence as the primary product. Every formulation is synthesized domestically, lyophilized to strict specifications, and validated by independent analytical laboratories before release.
The 8-Stage Genesis Protocol
From solid-phase synthesis to cryptographic lot release.
Raw Material Sourcing
Pharmaceutical-grade protected amino acid building blocks (Fmoc/tBu chemistry) with verified optical purity.
Solid-Phase Synthesis
Automated microwave-assisted or continuous-flow SPPS with real-time UV monitoring of coupling efficiencies.
Preparative RP-HPLC
Multi-stage preparative reverse-phase HPLC isolation to eliminate truncated sequences and diastereomers to ≥ 99.0%.
Freeze-Drying Cycle
Controlled multi-phase primary/secondary lyophilization to establish stable amorphous cake structure with < 3% residual moisture.
Aseptic Vialing
Automated fill/finish in cleanroom environments with medical-grade chlorobutyl stoppers and flip-off seals.
Independent 3rd-Party Testing
Random batch samples sent directly to Janoshik Analytical for independent HPLC purity, ESI-MS mass spec, and endotoxin screening.
Documented Release Gate
Formal certificate generation and internal QA release sign-off before any lot enters the professional distribution network.
Follow the Lot™ Archive
Permanent archiving of analytical reports in the searchable COA library, accessible by lot number anytime.
Understanding the Analytical Testing Panels
What each test establishes and how to interpret raw laboratory reports.
Reverse-Phase HPLC (RP-HPLC)
Measures relative chromatographic purity. By passing the peptide through a C18 hydrophobic stationary phase under an acetonitrile/water gradient, impurities and truncated fragments separate by retention time, yielding an accurate area-under-the-curve percentage.
Electrospray Ionization MS (ESI-MS)
Confirms molecular identity. High-resolution mass spectrometry verifies the exact monoisotopic/average molecular mass (m/z) of the compound against theoretical calculations, ruling out amino acid substitutions.
LAL Bacterial Endotoxin Screening
Ensures safety thresholds. Kinetic turbidimetric or chromogenic Limulus Amebocyte Lysate (LAL) testing per USP <85> validates that bacterial endotoxin levels remain below 0.05 EU/mg.
Quantitative Peptide Content
Measures absolute milligram content. Quantitative nitrogen or amino acid analysis (AAA) establishes the true net peptide quantity per vial, distinct from counter-ion salts or moisture weight.